Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

GLP-1 is a natural hormone produced by the intestines in response to food ... Backed By Incredible Clinical Trials GLP-1 and GIP antagonists are the best studied weight loss medications in history.

PRNewswire/ -- (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today ...

On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...

Tirzepatide is a dual GLP-1/GIP receptor agonist that has been approved by the ... Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta ...

Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it becomes available to the public, a Monday study found. Obese adults who ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

The glucose-dependent insulinotropic polypeptide (GIP), another gastrointestinal hormone, plays a similar role to the GLP-1 hormone, and GIP receptors are another target for weight-loss drugs.

NEW YORK, Dec 25: Recent pharmaceutical innovations have opened a new path for weight loss through drugs based on gut hormones such as GLP-1 and GIP. These hormones help regulate appetite, and ...